Back To Results

COVID-19

January 14, 2021

COVID-19 Vaccinations and Psoriatic Disease

Episode 111

COVID-19 vaccines have arrived! COVID-19 Task Force Co-Chairs, dermatologist Dr. Joel Gelfand, Psoriasis and Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Psoriasis Center, University of Rochester Medical Center return to discuss vaccine safety, effectiveness, and use with psoriatic disease treatments.

This program is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB. 

A young man gets prepped for a vaccine by a health care worker.
Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2021 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.